What does suppressive therapy mean?
Suppressive therapy means that the goal is a TSH below the normal range and is used in thyroid cancer patients to prevent growth of any remaining cancer cells and sometimes in patients with thyroid nodules to prevent nodule growth.
What is suppressive therapy for cold sores?
Suppressive therapy with oral valacyclovir was more effective than episodic therapy with oral valacyclovir in reducing the frequency of recurrences of herpes labialis and prolonging the time to first recurrence and was also similarly well-tolerated.
What is suppressive antiviral therapy?
Suppressive therapy — Suppressive therapy is antiviral treatment that is taken every day to prevent outbreaks. The advantage of suppressive therapy is that it decreases the frequency and duration of recurrences, and can reduce the risk of transmitting HSV to an uninfected sex partner.
How effective is suppressive therapy?
Suppressive therapy reduces frequency of genital herpes recurrences by 70%–80% among patients who have frequent recurrences (469–472). Persons receiving such therapy often report having experienced no symptomatic outbreaks. Suppressive therapy also is effective for patients with less frequent recurrences.
What is episodic treatment?
The specific aims of episodic treatment are to shorten the duration of the outbreak, reduce the severity of pain, and hasten lesion healing.
What is suppressive T4 therapy?
Patients treated for differentiated thyroid cancer take a daily thyroid hormone replacement pill called levothyroxine (also known as T4). They take it both to avoid hypothyroidism (underactive thyroid condition) and to prevent growth or recurrence of their thyroid cancer.
How do you stop hormonal cold sores?
Other actions a person with HSV-1 can do to reduce the frequency of cold sores include:
- avoiding triggers, such as sun exposure or eczema flares.
- managing stress.
- washing the hands frequently.
- avoiding people who are sick.
How long does it take for Valtrex suppressive therapy to work?
It can take up to seven to 10 days for Valtrex to start working for some people, while others may feel relief from their symptoms after a day or two. The amount of time it takes your symptoms to go away will depend on your age, the severity of your symptoms, and your metabolism.
What is 1g of Valtrex?
VALTREX 1 gram (Valtrex 1 gram) Valtrex is used in the treatment of cold sores; herpes simplex, suppression; herpes simplex, mucocutaneous/immunocompetent host; herpes simplex, mucocutaneous/immunocompromised host; herpes zoster and belongs to the drug class purine nucleosides.
What does a suppressed TSH level mean?
In most instances, the normal TSH range is approximately 0.4-4.5 mIU/L. A low TSH level is between 0.1-0.4 mIU/L and a suppressed TSH level is one below 0.1 mIU/L. In determining treatment for SH, it is important to know whether the patient’s TSH is low or suppressed.
What is suppressive therapy for herpes?
Suppressive therapy consists of taking a regular dose of antivirals every day whether you have an outbreak or not. The purpose is to not only prevent outbreaks, but also to reduce the likelihood of transmitting herpes to a sexual partner. If you opt for suppressive therapy, one of the most common antiviral medications is Valtrex, or valacyclovir.
What is the difference between intermittent and suppressive therapy?
Intermittent treatment consists of taking an antiviral drug when you experience an outbreak to lessen the severity of symptoms and shorten their duration. Suppressive therapy consists of taking a regular dose of antivirals every day whether you have an outbreak or not.
How effective is suppressive therapy for HSV-2?
In couples where one partner had HSV-2 and the other did not, a study showed that suppressive therapy reduced the risk of overall acquisition by almost 50%. One study showed that people who had 12 outbreaks per year reduced them to less than two per year after a year of herpes suppressive therapy.
Does suppressive antiviral therapy reduce risk of HIV transmission?
Suppressive antiviral therapy among persons with HIV and HSV infection does not reduce the risk for either HIV transmission or HSV-2 transmission to susceptible sex partners ( 88, 505 ).